Cargando…

MicroRNA-218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15-hydroxyprostaglandin dehydrogenase [NAD(+)]

The chondrogenic differentiation of synovial mesenchymal stem cells (SMSCs) is regulated by essential transcription factors and signaling cascades. However, the precise mechanisms involved in this process remain unclear. MicroRNAs (miRs/miRNAs) are undersized non-coding RNAs responsible for the post...

Descripción completa

Detalles Bibliográficos
Autores principales: Cong, Ruijun, Tao, Kun, Fu, Peiliang, Lou, Lieming, Zhu, Yuchang, Chen, Song, Cai, Xinyu, Mao, Lingzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779987/
https://www.ncbi.nlm.nih.gov/pubmed/29039590
http://dx.doi.org/10.3892/mmr.2017.7795
_version_ 1783294655657410560
author Cong, Ruijun
Tao, Kun
Fu, Peiliang
Lou, Lieming
Zhu, Yuchang
Chen, Song
Cai, Xinyu
Mao, Lingzhou
author_facet Cong, Ruijun
Tao, Kun
Fu, Peiliang
Lou, Lieming
Zhu, Yuchang
Chen, Song
Cai, Xinyu
Mao, Lingzhou
author_sort Cong, Ruijun
collection PubMed
description The chondrogenic differentiation of synovial mesenchymal stem cells (SMSCs) is regulated by essential transcription factors and signaling cascades. However, the precise mechanisms involved in this process remain unclear. MicroRNAs (miRs/miRNAs) are undersized non-coding RNAs responsible for the post-transcriptional regulation of gene expression, by binding to the 3′-untranslated regions (3′-UTRs) of their target mRNAs. miRNAs may constitute a promising tool to regulate SMSC differentiation and to advance the controlled differentiation of SMSCs in therapeutic applications. The aim of the present study was to examine the role of miR-218 in SMSC differentiation towards chondrocytes. The present study comparatively analyzed the expression profile of known miRNAs and specific target genes in SMSCs between early and late differentiation stages. Western blotting and reverse transcription-quantitative polymerase chain reaction analysis of gene expression demonstrated the upregulation of 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-HPGD), prostaglandin E2 (PGE2) and rate limiting enzymes responsible for the synthesis of PGE2 precursors throughout chondrogenesis. Through correlation analysis, it was observed that there was a significant association between miR-128, 15-HPGD gene expression, 15-HPGD protein expression and microsomal prostaglandin E synthase 1. Further experiments demonstrated that miR-218 decreased PGE2 concentration by binding to the 3′-UTR of 15-HPGD. Using an immunofluorescence reporting system, it was observed that miR-218 regulated the expression of 15-HPGD during the differentiation of SMSCs into cartilage, and subsequently inhibited osteogenesis during chondrogenesis by acting on the 3′UTR of 15-HPGD. Therefore, miR-218 may be an important regulator targeting osteogenic factors and modulating cartilage formation and differentiation. The results of the present study provided a novel insight beneficial to cellular manipulation methods during cartilage regeneration, and in cartilage tissue engineering research.
format Online
Article
Text
id pubmed-5779987
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57799872018-02-12 MicroRNA-218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Cong, Ruijun Tao, Kun Fu, Peiliang Lou, Lieming Zhu, Yuchang Chen, Song Cai, Xinyu Mao, Lingzhou Mol Med Rep Articles The chondrogenic differentiation of synovial mesenchymal stem cells (SMSCs) is regulated by essential transcription factors and signaling cascades. However, the precise mechanisms involved in this process remain unclear. MicroRNAs (miRs/miRNAs) are undersized non-coding RNAs responsible for the post-transcriptional regulation of gene expression, by binding to the 3′-untranslated regions (3′-UTRs) of their target mRNAs. miRNAs may constitute a promising tool to regulate SMSC differentiation and to advance the controlled differentiation of SMSCs in therapeutic applications. The aim of the present study was to examine the role of miR-218 in SMSC differentiation towards chondrocytes. The present study comparatively analyzed the expression profile of known miRNAs and specific target genes in SMSCs between early and late differentiation stages. Western blotting and reverse transcription-quantitative polymerase chain reaction analysis of gene expression demonstrated the upregulation of 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-HPGD), prostaglandin E2 (PGE2) and rate limiting enzymes responsible for the synthesis of PGE2 precursors throughout chondrogenesis. Through correlation analysis, it was observed that there was a significant association between miR-128, 15-HPGD gene expression, 15-HPGD protein expression and microsomal prostaglandin E synthase 1. Further experiments demonstrated that miR-218 decreased PGE2 concentration by binding to the 3′-UTR of 15-HPGD. Using an immunofluorescence reporting system, it was observed that miR-218 regulated the expression of 15-HPGD during the differentiation of SMSCs into cartilage, and subsequently inhibited osteogenesis during chondrogenesis by acting on the 3′UTR of 15-HPGD. Therefore, miR-218 may be an important regulator targeting osteogenic factors and modulating cartilage formation and differentiation. The results of the present study provided a novel insight beneficial to cellular manipulation methods during cartilage regeneration, and in cartilage tissue engineering research. D.A. Spandidos 2017-12 2017-10-17 /pmc/articles/PMC5779987/ /pubmed/29039590 http://dx.doi.org/10.3892/mmr.2017.7795 Text en Copyright: © Cong et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Cong, Ruijun
Tao, Kun
Fu, Peiliang
Lou, Lieming
Zhu, Yuchang
Chen, Song
Cai, Xinyu
Mao, Lingzhou
MicroRNA-218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15-hydroxyprostaglandin dehydrogenase [NAD(+)]
title MicroRNA-218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15-hydroxyprostaglandin dehydrogenase [NAD(+)]
title_full MicroRNA-218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15-hydroxyprostaglandin dehydrogenase [NAD(+)]
title_fullStr MicroRNA-218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15-hydroxyprostaglandin dehydrogenase [NAD(+)]
title_full_unstemmed MicroRNA-218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15-hydroxyprostaglandin dehydrogenase [NAD(+)]
title_short MicroRNA-218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15-hydroxyprostaglandin dehydrogenase [NAD(+)]
title_sort microrna-218 promotes prostaglandin e2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15-hydroxyprostaglandin dehydrogenase [nad(+)]
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779987/
https://www.ncbi.nlm.nih.gov/pubmed/29039590
http://dx.doi.org/10.3892/mmr.2017.7795
work_keys_str_mv AT congruijun microrna218promotesprostaglandine2toinhibitosteogenicdifferentiationinsynovialmesenchymalstemcellsbytargeting15hydroxyprostaglandindehydrogenasenad
AT taokun microrna218promotesprostaglandine2toinhibitosteogenicdifferentiationinsynovialmesenchymalstemcellsbytargeting15hydroxyprostaglandindehydrogenasenad
AT fupeiliang microrna218promotesprostaglandine2toinhibitosteogenicdifferentiationinsynovialmesenchymalstemcellsbytargeting15hydroxyprostaglandindehydrogenasenad
AT loulieming microrna218promotesprostaglandine2toinhibitosteogenicdifferentiationinsynovialmesenchymalstemcellsbytargeting15hydroxyprostaglandindehydrogenasenad
AT zhuyuchang microrna218promotesprostaglandine2toinhibitosteogenicdifferentiationinsynovialmesenchymalstemcellsbytargeting15hydroxyprostaglandindehydrogenasenad
AT chensong microrna218promotesprostaglandine2toinhibitosteogenicdifferentiationinsynovialmesenchymalstemcellsbytargeting15hydroxyprostaglandindehydrogenasenad
AT caixinyu microrna218promotesprostaglandine2toinhibitosteogenicdifferentiationinsynovialmesenchymalstemcellsbytargeting15hydroxyprostaglandindehydrogenasenad
AT maolingzhou microrna218promotesprostaglandine2toinhibitosteogenicdifferentiationinsynovialmesenchymalstemcellsbytargeting15hydroxyprostaglandindehydrogenasenad